Literature DB >> 15671997

Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure.

Patrick Bose1, Simon Black, Mamed Kadyrov, Ute Weissenborn, Joseph Neulen, Lesley Regan, Berthold Huppertz.   

Abstract

OBJECTIVE: Live birth rates are increased by treatment with heparin and aspirin in cases of poor pregnancy outcome such as antiphospholipid syndrome. Both drugs may attenuate miscarriage by inhibiting aberrant coagulation or by modulating trophoblast apoptosis. Here we assessed their roles in trophoblast apoptosis in vitro. STUDY
DESIGN: BeWo cells and placental villi were cultured in sera from women with successful or failing in vitro fertilization, with and without heparin or aspirin. Apoptosis was assessed by using DNA laddering, cytokeratin 18 neoepitope formation, Bcl-2, and caspase 7 expression.
RESULTS: In BeWo cells, sera from in vitro fertilization failure increased trophoblast apoptosis, whereas heparin and aspirin reversed these effects. In villous trophoblast, heparin increased Bcl-2 and cytokeratin 18 protein expression. Heparin and aspirin inhibited DNA laddering.
CONCLUSION: Heparin and aspirin modulate trophoblast apoptosis suggesting a direct impact on trophoblast biology, thus providing an additional mechanism to explain the clinical benefits of heparin and aspirin on recurrent pregnancy loss.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671997     DOI: 10.1016/j.ajog.2004.09.029

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  22 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Fbxw8 is involved in the proliferation of human choriocarcinoma JEG-3 cells.

Authors:  Ping Lin; Jiejun Fu; Binjiahui Zhao; Feng Lin; Haifeng Zou; Leiyu Liu; Cheng Zhu; Hongmei Wang; Xiaoguang Yu
Journal:  Mol Biol Rep       Date:  2010-09-29       Impact factor: 2.316

Review 3.  Disturbances in placental immunology: ready for therapeutic interventions?

Authors:  Sinuhe Hahn; Anurag Kumar Gupta; Carolyn Troeger; Corinne Rusterholz; Wolfgang Holzgreve
Journal:  Springer Semin Immunopathol       Date:  2006-04-26

4.  Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor.

Authors:  Alan D Bolnick; Jay M Bolnick; Hamid-Reza Kohan-Ghadr; Brian A Kilburn; Omar J Pasalodos; Pankaj K Singhal; Jing Dai; Michael P Diamond; D Randall Armant; Sascha Drewlo
Journal:  Hum Reprod       Date:  2017-06-01       Impact factor: 6.918

5.  Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial.

Authors:  Elisabeth Pasquier; Luc de Saint Martin; Caroline Bohec; Céline Chauleur; Florence Bretelle; Gisèle Marhic; Grégoire Le Gal; Véronique Debarge; Frédéric Lecomte; Christine Denoual-Ziad; Véronique Lejeune-Saada; Serge Douvier; Michel Heisert; Dominique Mottier
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

Review 6.  Anticoagulant therapy and pregnancy.

Authors:  Aiko Makino; Mayumi Sugiura-Ogasawara
Journal:  Reprod Med Biol       Date:  2008-02-01

Review 7.  Autoantibodies and coagulation in reproductive medicine.

Authors:  Hidehiko Matsubayashi
Journal:  Reprod Med Biol       Date:  2009-07-18

8.  Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem/stromal cells and reduces their production of pro-inflammatory cytokines.

Authors:  Ramin Khanabdali; Aida Shakouri-Motlagh; Sarah Wilkinson; Padma Murthi; Harry M Georgiou; Shaun P Brennecke; Bill Kalionis
Journal:  J Mol Med (Berl)       Date:  2018-10-01       Impact factor: 4.599

Review 9.  Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.

Authors:  Amelia Ruffatti; Ariela Hoxha; Maria Favaro; Marta Tonello; Anna Colpo; Umberto Cucchini; Alessandra Banzato; Vittorio Pengo
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 10.  Autoimmunity and recurrent pregnancy losses.

Authors:  Ricard Cervera; Juan Balasch
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.